Fig. 3

Prognosis based on the seven cuproptosis-related lncRNA signatures. A–C Kaplan–Meier survival curves of overall survival of AML samples in the training (A), validation (B), and whole cohorts (C); D–F Risk scores of the AML samples in the training (D), validation (E), and whole cohorts (F). G–I Survival status of the AML samples in the training (G), validation (H), and whole cohorts (I); J–L Heatmaps of the expression levels of the seven cuproptosis-related lncRNAs in the training (J), validation (K), and whole cohorts (L)